These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 8799398

  • 1. Circulating soluble intercellular adhesion molecule-1 in type C viral hepatitis.
    Yang SS, Tsai G, Wu CH, Chen DS.
    Hepatogastroenterology; 1996; 43(9):575-81. PubMed ID: 8799398
    [Abstract] [Full Text] [Related]

  • 2. Serum levels of intercellular adhesion molecule-1 and nitric oxide in patients with chronic hepatitis related to hepatitis C virus: connection fibrosis.
    Pata C, Yazar A, Altintas E, Polat G, Aydin O, Tiftik N, Konca K.
    Hepatogastroenterology; 2003; 50(51):794-7. PubMed ID: 12828087
    [Abstract] [Full Text] [Related]

  • 3. Serum level of soluble intercellular adhesion molecule-1 in patients with acute viral hepatitis A or acute viral hepatitis B: lack of correlation with severity of the disease.
    Magiera M, Kucharz EJ, Chelmicka A, Moron-Swierszcz J, Witor A, Witor A, Kotulska A.
    Rom J Intern Med; 2003; 38-39():97-101. PubMed ID: 15529577
    [Abstract] [Full Text] [Related]

  • 4. Significance of anti-interferon-alpha2 and sICAM-1 activities in the sera of viral hepatitis B and C patients treated with human recombinant interferon-alpha2.
    Stancek D, Fuchsberger N, Oltman M, Schmeisser H, Kontsek P, Jahnová E, Hajnická V.
    Acta Virol; 2001; 45(5-6):287-92. PubMed ID: 12083327
    [Abstract] [Full Text] [Related]

  • 5. Immunoresponsiveness in chronic hepatitis C patients: correlation between tissue and serum findings.
    Piazzolla G, Tortorella C, Fiore G, Serrone M, Caccetta L, Jirillo E, Schiraldi O, Antonaci S.
    Immunopharmacol Immunotoxicol; 1998 Aug; 20(3):337-54. PubMed ID: 9736440
    [Abstract] [Full Text] [Related]

  • 6. Early increase in levels of soluble inter-cellular adhesion molecule-1 (sICAM-1); potential risk factor for the acute coronary syndromes.
    O'Malley T, Ludlam CA, Riemermsa RA, Fox KA.
    Eur Heart J; 2001 Jul; 22(14):1226-34. PubMed ID: 11440495
    [Abstract] [Full Text] [Related]

  • 7. Soluble ICAM-1 (sICAM-1) in biliary atresia and its relationship to disease activity.
    Minnick KE, Kreisberg R, Dillon PW.
    J Surg Res; 1998 Apr; 76(1):53-6. PubMed ID: 9695739
    [Abstract] [Full Text] [Related]

  • 8. Hyperhyaluronanemia in alcoholic hepatitis is associated with increased levels of circulating soluble intercellular adhesion molecule-1.
    Hill DB, Deaciuc IV, McClain CJ.
    Alcohol Clin Exp Res; 1998 Sep; 22(6):1324-7. PubMed ID: 9756049
    [Abstract] [Full Text] [Related]

  • 9. Circulating ICAM-1 (sCD54) and LFA-3 (sCD58) in chronic hepatitis B--a longitudinal study in patients treated with interferon-alpha.
    Knolle PA, Eckardt AJ, Protzer-Knolle U, Schirmacher P, Dienes HP, Meyer zum Büschenfelde KH, Gerken G.
    Z Gastroenterol; 1997 Jun; 35(6):459-67. PubMed ID: 9231990
    [Abstract] [Full Text] [Related]

  • 10. Measurement of human intercellular adhesion molecule 1 in the blood is useful for predicting the occurrence of hepatocellular carcinomas from chronic hepatitis C and liver cirrhosis.
    Moriyama M, Matsumura H, Shioda J, Aoki H, Nakamura H, Arakawa Y, Nirei K, Yamagami H, Kaneko M, Tanaka N, Arakawa Y.
    Intervirology; 2006 Jun; 49(6):327-38. PubMed ID: 16926545
    [Abstract] [Full Text] [Related]

  • 11. Time course of plasma soluble intercellular adhesion molecule-1 (sICAM-1) is related to severity of acute pancreatitis.
    Kaufmann P, Demel U, Tilz GP, Krejs GJ.
    Hepatogastroenterology; 1999 Jun; 46(28):2565-71. PubMed ID: 10522042
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Relevance of nutritional route and intercellular adhesion molecule-1 in patients with acute renal failure and its prognostic implications.
    Sezer MT, Demir M, Gungor G, Yavuz L.
    J Ren Nutr; 2008 May; 18(3):288-93. PubMed ID: 18410885
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Relation of serum levels of the soluble cytoadhesion molecules sVCAM-1 and sICAM-1 to selected factors in the cytokine network in multiple myeloma].
    Scudla V, Budíková M, Bacovský J, Opíchalová D, Farbiaková V.
    Cas Lek Cesk; 2000 Jul 05; 139(13):401-6. PubMed ID: 10971970
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Hemodialysis procedure does not affect the levels of sICAM-1 and sVCAM-1 in patients with end stage renal disease.
    Liakopoulos V, Eleftheriadis T, Kyropoulos T, Voliotis G, Potamianos S, Zengos N, Stefanidis I, Heintz B.
    Ren Fail; 2005 Jul 05; 27(3):315-21. PubMed ID: 15957549
    [Abstract] [Full Text] [Related]

  • 20. [Change of serum soluble intercellular adhesion molecule and basic fibroblast growth factor in patients with acute cerebral infarction and its clinical significance].
    Song S, Zheng X, Wen S, Huang J, Ding D.
    Zhonghua Yi Xue Za Zhi; 2002 Nov 10; 82(21):1447-9. PubMed ID: 12509902
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.